4.7 Review

Developing inhaled drugs for respiratory diseases: A medicinal chemistry perspective

Journal

DRUG DISCOVERY TODAY
Volume 27, Issue 1, Pages 134-150

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2021.09.005

Keywords

Inhaled; Respiratory; Lung; Asthma; COPD; Design; Bronchodilators; DPI; Medicinal chemistry; Lung retention

Ask authors/readers for more resources

Despite the devastating impact of many lung diseases on human health, there is still a significant unmet medical need in respiratory diseases, for which inhaled delivery represents a crucial strategy. When designing inhaled drugs, the medicinal chemist must carefully balance the physicochemical properties of the molecule to achieve optimal target engagement in the lung. Although the medicinal chemistry strategy is unique for each project, general guidelines aiding inhaled drug design can be applied.
Despite the devastating impact of many lung diseases on human health, there is still a significant unmet medical need in respiratory diseases, for which inhaled delivery represents a crucial strategy. More guidance on how to design and carry out multidisciplinary inhaled projects is needed. When designing inhaled drugs, the medicinal chemist must carefully balance the physicochemical properties of the molecule to achieve optimal target engagement in the lung. Although the medicinal chemistry strategy is unique for each project, and will change depending on multiple factors, such as the disease, target, systemic risk, delivery device, and formulation, general guidelines aiding inhaled drug design can be applied and are summarised in this review.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available